All American Peptide (Kovaleskis)
This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Documented as March 24-25, 2022. Sources for this entry are named inline below and numbered in full on the parent archive page.
Sylvia and Keith Kovaleski pleaded guilty to conspiring to distribute misbranded drugs and unapproved new drugs, conduct spanning 2014 to January 2019. Forfeiture exceeded $3 million (Amtrak OIG). The business had sold tadalafil, SARMs, peptides, and other unapproved substances online during that period.
Why it still matters: established that “research use only” marketing did not insulate vendors from conspiracy-to-distribute-misbranded-drugs charges. The $3M forfeiture signaled the scale of case DOJ was willing to pursue. The Kovaleskis were small-scale relative to what came later, and they still lost three million dollars.
Primary sources: Amtrak OIG press release; DOJ Maryland announcement.